Lambda Research, Inc. – FDA 483, Aug 26, 2022
An FDA inspection of Lambda Research Inc, a control testing laboratory in Cincinnati, OH, revealed significant deficiencies in their quality control unit's procedures and documentation. The firm failed to adequately review and document periodic proficiency testing for laboratory personnel performing X-ray diffraction analysis of pharmaceutical samples. Additionally, the quality unit lacked written procedures outlining the scope and frequency of Current Good Manufacturing Practice (CGMP) training for relevant personnel.
ID · f00ab4c9-203e-40c2-918f-c275d79d8fac
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.